SICURANZA ANNA | Professor page

Caggiano, V., Sbalchiero, J., Frassi, M., Martin-Nares, E., Hinojosa-Azaola, A., Sikora, M., et al. (2026). Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registries. FRONTIERS IN MEDICINE, 12 [10.3389/fmed.2025.1659758]. - view more
Gavioli, F., Caggiano, V., Sbalchiero, J., Frassi, M., Crisafulli, F., Cavazzana, I., et al. (2026). VEXAS syndrome and cancer: Insights about a possible “Tip of the Iceberg”. Ambidirectional data from the international AIDA network registries. SEMINARS IN ARTHRITIS AND RHEUMATISM, 77 [10.1016/j.semarthrit.2026.152932]. - view more
Mutti, S., Cavalleri, A., Sicuranza, A., Pacelli, P., Ielo, C., Paolini, L., et al. (2025). Tracking leukemic residuals: dissecting the inverse relationship between CD26+ stem cells and extracellular BCR::ABL1 transcript in Chronic Myeloid Leukemia (CML). STEM CELLS TRANSLATIONAL MEDICINE, 14(12) [10.1093/stcltm/szaf062]. - view more
Santoni, A., Malchiodi, M., Zappone, E., Cartocci, A., Sicuranza, A., Pacelli, P., et al. (2025). Low rate of infectious mortality omitting fluoroquinolone prophylaxis in high-risk hematological patients, a single centre experience. FRONTIERS IN MICROBIOLOGY, 16 [10.3389/fmicb.2025.1632055]. - view more
Caroni, F., Sammartano, V., Pacelli, P., Sicuranza, A., Malchiodi, M., Dragomir, A., et al. (2025). Minimal Residual Disease Significance in Multiple Myeloma Patients Treated with Anti-CD38 Monoclonal Antibodies. PHARMACEUTICALS, 18(2) [10.3390/ph18020159]. - view more

All publications